Matches in Wikidata for { <http://www.wikidata.org/entity/Q81326053> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q81326053 description "artículu científicu espublizáu n'abril de 2008" @default.
- Q81326053 description "im April 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81326053 description "scientific article published on 01 April 2008" @default.
- Q81326053 description "wetenschappelijk artikel" @default.
- Q81326053 description "наукова стаття, опублікована у квітні 2008" @default.
- Q81326053 name "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 name "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 type Item @default.
- Q81326053 label "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 label "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 prefLabel "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 prefLabel "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 P1433 Q81326053-6AD6252C-ECA6-4658-ADC3-8DAC9DCDBFF2 @default.
- Q81326053 P1476 Q81326053-4545A3F2-1F25-47A8-BCC5-D57D065AB375 @default.
- Q81326053 P2093 Q81326053-3A44973E-F982-4301-8E5A-F6B0F7EDBAF4 @default.
- Q81326053 P2093 Q81326053-4CA00510-329B-4196-9B67-29884333C21B @default.
- Q81326053 P2093 Q81326053-749256F6-05A7-4B22-BA72-20DC32FC67B2 @default.
- Q81326053 P2093 Q81326053-F4919688-188C-49A4-A75F-31FF8A227C10 @default.
- Q81326053 P304 Q81326053-B1750ED4-C05D-402F-8C24-1F6C5DD8A529 @default.
- Q81326053 P31 Q81326053-842B9350-E66E-48FE-BA3B-20B21086FC6F @default.
- Q81326053 P356 Q81326053-D1742FBA-DA04-4920-B7D2-66D5E6B2C997 @default.
- Q81326053 P433 Q81326053-BBC99DBE-5493-46EF-9AD8-A149AE5BAB18 @default.
- Q81326053 P478 Q81326053-B3B4F20B-7152-4AAB-9D10-B4D4EC3FF95C @default.
- Q81326053 P50 Q81326053-53A67A01-907C-4A48-9AAD-786E35B652C2 @default.
- Q81326053 P577 Q81326053-6A06A083-FC9C-4825-8743-F1D3E00403A3 @default.
- Q81326053 P698 Q81326053-597976CB-216C-4663-A307-5DC2663266DF @default.
- Q81326053 P921 Q81326053-40D30CE0-5A61-46BF-8EBB-56AB8A85136D @default.
- Q81326053 P921 Q81326053-49775A08-0F66-4BD4-AB6F-85653A0D9252 @default.
- Q81326053 P356 J.CLINTHERA.2008.03.014 @default.
- Q81326053 P698 18498923 @default.
- Q81326053 P1433 Q15716601 @default.
- Q81326053 P1476 "Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria" @default.
- Q81326053 P2093 "Bernhard Resch" @default.
- Q81326053 P2093 "Mark J C Nuijten" @default.
- Q81326053 P2093 "Walter Gusenleitner" @default.
- Q81326053 P2093 "Wolfgang Wittenberg" @default.
- Q81326053 P304 "749-760" @default.
- Q81326053 P31 Q13442814 @default.
- Q81326053 P356 "10.1016/J.CLINTHERA.2008.03.014" @default.
- Q81326053 P433 "4" @default.
- Q81326053 P478 "30" @default.
- Q81326053 P50 Q59687365 @default.
- Q81326053 P577 "2008-04-01T00:00:00Z" @default.
- Q81326053 P698 "18498923" @default.
- Q81326053 P921 Q1754768 @default.
- Q81326053 P921 Q40 @default.